| Year | Citation | Publication Type | Authors |
|---|---|---|---|
| 2018 | Myelodysplasia, hematological malignancies and other cancers in patients with severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood 2018 | Abstract | Dale DC, Bolyard AA, Alter B, Bonilla MA, Connelly J, Link D, Rosenberg P, Shimamura A, Walkovich KJ, Newburger P. |
| 2016 | Analysis of leukemogenic effects of RUNX1 & CSF3R mutations using congenital neutropenia (CN)/AML patient- derived induced pluripotent stem cells (IPSCS). Blood. 2016;128:404 | Abstract | Dannenmann B, Klimiankou M, Lindner C, etal. |
| 2016 | Two cases of cyclic neutropenia with acquired CSF3R mutations, with 1 developing AML. Blood. 2016;127:2638-41. PMID: 27030388; | Journal Article | Klimiankou M, Mellor-Heineke S, Klimenkova O, etal. |
| 2014 | Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood. 2014;123:2229-37. PMID: 24523240 | Journal Article | Skokowa J, Steinemann D, Katsman-Kuipers JE, Zeidler C, Klimenkova O, Klimiankou M, Unalan M, Kandabarau S, Makaryan V, Beekman R, Behrens K, Stocking C, Obenauer J, Schnittger S, Kohlmann A, Valkhof MG, Hoogenboezem R, Göhring G, Reinhardt D, Schlegelberger B, Stanulla M, Vandenberghe P, Donadieu J, Zwaan CM, Touw IP, van den Heuvel- Eibrink MM, Dale DC, Welte K. |
| 2014 | The association of mutations in RUNX1 and CSF3R with the development of leukemia in severe congenital neutropenia: a new pathway in leukemogenesis. Blood. 2014 Apr 3;123(14):2229-37. Epub 2014 Feb 12. | Journal Article | Skokowa J, Steinemann D, Zeidler C, Makaryan V, Beekman M, Klimiankou M, Ünelan S, Kandabarau S, Schnittger S, Kohlmann A, Valkhof MG, Hoogenboezem R, Göhring G, Schegelberger B, Stanulla M, Vandenberghe P, Donadieu J, Touw IP, Dale DC, Welte K. |
| 2013 | Comprehensive Genomic Evaluation for Inherited Bone Marrow Failure and Myelodysplastic Syndromes, American Society of Hematology, 2013 | Abstract | Zhang, MY, Keel, SB, Walsh, T, Lee, M, Pritchard, C, Jeng, M, Watts, A, Abkowitz, JL, King, MC, and Shimamura, A. |
| 2013 | Cooperativity of RUNX1 and CSF3R mutations in the development of leukemia in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood. (ASH Annual Meeting Abstracts) 2013;122:444. | Abstract | Steinemann D, Katsman-Kuipers J, Zeidler C, Klimenkova O, Klimiankou M, Uenalan M, Kandabarau S, Makaryan V, Beekman R, Stocking C, Obenauer J, Schnittger S, Kohlmann A, Valkhof M, Hoogenboezem R, Göhring G, Reinhardt D, Schlegelberger B, Stanulla M, Vandenberghe P, Donadieu J, Zwaan M, Touw IP, van den Heuvel-Eibrink MM, Dale DC, Welte K. |
| 2012 | RUNX1 mutations are the most frequent leukemia associated mutations in congenital neutropenia patients. (ASH Annual Meeting Abstracts). Blood. 2012;120:7. | Abstract | Skokowa J, Steinemann D, Makaryan V, Klimiankou M, Schnittger,S, Kohlmann A, Schlegelberger B, Zeidler C, Dale DC, Welte K. |
| 2011 | Update on the risk of secondary leukemia in genetic subgroups (ELANE, HAX1, WAS, G6PC3, p14) of congenital neutropenia in Europe. Blood (ASH Annual Meeting Abstracts). 2011;118:1106. | Abstract | Zeidler C, Vandenberghe P, Schäfer I, Hoy L, Zimmermann M, Germeshausen M, Welte K. |
| 2010 | Malignancies and Survival Patterns in the National Cancer Institute Inherited Bone Marrow Failure Syndromes Cohort Study. British Journal of Haematology 150:179-188, 2010. PMCID: PMC3125983. | Journal Article | Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Carr A, Greene MH, Rosenberg PS |
| 2010 | Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J. Haematol. 2010;150:196-9. PMCID: PMC2906693 | Journal Article | Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link D, Newburger P, Shimamura A, Welte K, Dale DC. |
| 2010 | Stable Long-Term Risk of Leukaemia in Patients with Severe Congenital Neutropenia Maintained on G- CSF Therapy. B J Haematol. April 29, 2010: 7-1048. PMID 20456363. | Article | Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link DC, Newburger PE, Shimamura A, Welte K, Dale DC. |
| 2009 | Update on the risk of leukemia in genetic subgroups of congenital neutropenia (CN): comparison of patients with known gene mutations ( ELA2 , HAX1, WAS, G6PC3, P14) . (ASH Annual Meeting Abstracts). Blood. 2009;114:3597. | Abstract | Zeidler C, Donadieu J, Bolyard AA, Vandenberghe P, Pracht G, Beaupain B, Hoy L, Zimmermann M, Bellanné-Chantelot C, Link D, Klein C, Germeshausen M, Dale DC, Welte K, for the Severe Chronic Neutropenia International Registry (SCNIR) and the French Neutropenia Registry. |
| 2009 | Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy. (ASH Annual Meeting Abstracts). Blood. 2009;114:3206. | Abstract | Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Dror Y, Kinsey SE, Link DC, Shimamura A, Newburger PE, Boxer LA, Welte K, Dale DC. |